Updated predictive analysis of the WHO-defined molecular subgroups of low-grade gliomas within the high-risk treatment arms of NRG Oncology/RTOG 9802.

TY - CONF

T1 - Updated predictive analysis of the WHO-defined molecular subgroups of low-grade gliomas within the high-risk treatment arms of NRG Oncology/RTOG 9802.

AU - Bell, Erica Hlavin

AU - Won, Minhee

AU - Fleming, Jessica L.

AU - Becker, Aline P.

AU - McElroy, Joseph P.

AU - Shaw, Edward G.

AU - Mehta, Minesh P.

AU - Brachman, David G.

AU - Gertler, Stanley Z.

AU - Murtha, Albert D.

AU - Schultz, Christopher J.

AU - Johnson, David B.

AU - Laack, Nadia N.

AU - Hunter, Grant Kirton

AU - Crocker, Ian R.

AU - Chakravarti, Arnab

N1 - 2002 Background: This study sought to update the predictive significance of the three WHO-defined molecular glioma subgroups (IDHwt, IDHmt/noncodel, and IDHmt/codel) in the subset of specimens available for analysis in NRG Oncology/RTOG 9802, a phase III trial of high-risk low-grade gliomas (LGGs) treated with radiation (RT) with and without PCV after biopsy/surgical resection.

PY - 2019/5/20

Y1 - 2019/5/20

UR - http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2002

U2 - 10.1200/jco.2019.37.15_suppl.2002

DO - 10.1200/jco.2019.37.15_suppl.2002

M3 - Presentation

T2 - Journal of Clinical Oncology

Y2 - 1 January 2020

ER -